Wen Bu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Wnt/β-catenin signaling in development and cancer 5
- Oncology 17
- Cancer Cells and Metastasis 11
- HER2/EGFR in Cancer Research 4
- Cytokine Signaling Pathways and Interactions 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Yi Li (26 shared papers)Charlotta Lindvall (1 shared paper)Jeffrey M. Rosen (4 shared papers)Bart O. Williams (1 shared paper)Susan G. Hilsenbeck (6 shared papers)Weiwei Yang (2 shared papers)Zhimin Lu (2 shared papers)Inder M. Verma (1 shared paper)
- Journals
- Journal of Mammary Gland Biology and Neoplasia (2 papers)PLoS ONE (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Research (2 papers)Oncogene (2 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Wen Bu
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 295
- Oncology 502
- Molecular Biology 622
- Immunology 173
- Neurology 49
Countries citing papers authored by Wen Bu
This map shows the geographic impact of Wen Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Bu more than expected).
Fields of papers citing papers by Wen Bu
This network shows the impact of papers produced by Wen Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Bu. The network helps show where Wen Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 219 | |
| 2 | 2012 | 101 | |
| 3 | 2014 | 97 | |
| 4 | 2010 | 88 | |
| 5 | 2017 | 82 | |
| 6 | 2007 | 78 | |
| 7 | 2018 | 53 | |
| 8 | 2010 | 46 | |
| 9 | 2011 | 43 | |
| 10 | 2015 | 43 | |
| 11 | 2006 | 37 | |
| 12 | 2008 | 35 | |
| 13 | 2015 | 35 | |
| 14 | 2018 | 32 | |
| 15 | 2009 | 32 | |
| 16 | Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. | 1998 | 29 |
| 17 | 2013 | 23 | |
| 18 | 2020 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2016 | 11 |
About Wen Bu
Wen Bu is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Biotechnology, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Virus-based gene therapy research (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Animal Genetics and Reproduction (4 papers), HER2/EGFR in Cancer Research (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Cancer-related Molecular Pathways (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (295 citations), Oncology (502 citations), Molecular Biology (622 citations), Immunology (173 citations) and Neurology (49 citations). Wen Bu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Yi Li, Charlotta Lindvall, Jeffrey M. Rosen, Bart O. Williams, Susan G. Hilsenbeck, Weiwei Yang, Zhimin Lu, Inder M. Verma, Yanhua Zheng and Paul J. Chiao. Their work appears in journals such as Journal of Mammary Gland Biology and Neoplasia, PLoS ONE, Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.